Evidence mapPaperPMID 39310616Full record

ArticleCureus2024

Gender Differences in the Clinical Profile of Sodium-Glucose Cotransporter-2 Inhibitor-Related Urinary Tract Infections.

Mohammad Hayat Bhat, Mohammad Salem Baba, Md Ejaz Alam, Abid Hussain Bhat, Shahnawaz Mir, Basharat Qayoom Dar, Shoiab Mohd Patto, Pooran Sharma

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohammad Hayat BhatDepartment of Endocrinology, Government Superspeciality Hospital, Srinagar, IND.
Mohammad Salem BabaDepartment of Endocrinology, Government Superspeciality Hospital, Srinagar, IND.
Md Ejaz AlamDepartment of Endocrinology, Diabetes and Metabolism, Government Medical College, Srinagar, Srinagar, IND.
Abid Hussain BhatDepartment of Endocrinology, Government Superspeciality Hospital, Srinagar, IND.
Shahnawaz MirDepartment of Endocrinology, Government Superspeciality Hospital, Srinagar, IND.
Basharat Qayoom DarDepartment of Endocrinology, Government Superspeciality Hospital, Srinagar, IND.
Shoiab Mohd PattoDepartment of Endocrinology, Government Superspeciality Hospital, Srinagar, IND.
Pooran SharmaDepartment of Endocrinology, Government Superspeciality Hospital, Srinagar, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Sodium-glucose cotransporter-2 inhibitors (SGLT2Is) are a novel class of oral antidiabetic agents with proven cardiovascular and mortality benefits. By promoting glucosuria, SGLT2Is increase the risk of genital and urinary tract infections (UTIs), which remain uncomplicated in most cases. Comparative studies detailing the gender differences in the clinical profile of SGLT2I-related UTIs (SUTIs) are lacking. Hence, this study was designed to investigate the gender-related differences in the clinical profile of SUTIs. Methodology This prospective study enrolled 100 consecutive diabetes mellitus patients with UTI symptoms who were on SGLT2Is. In addition to collecting clinical details, patients were subjected to the following investigations: complete blood counts, urea, creatine, liver function, lipid components, urine analysis, urine culture, and ultrasonography. Results Females (n = 80) outnumbered males (n = 20). Although females were younger than males (53.68 ± 10.26 vs. 63.30 ± 10.75 years, p = 0.003), body mass index (29.84 ± 7.22 vs. 24.62 ± 3.10 kg/m

Indexed as

clinical profilegendersglt2isutiuti

Identifiers

PMID39310616
PMCPMC11416749

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.